Quest Diagnostics Inc (DGX) Return on equity 2016–2025
Quest Diagnostics Inc (DGX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
13.8%FY2025 · since FY2016: 13.9% → 13.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 13.8% | +1.0 pp |
| FY2024 | 12.9% | -0.7 pp |
| FY2023 | 13.5% | -2.5 pp |
| FY2022 | 16.1% | -14.9 pp |
| FY2021 | 31.0% | +9.8 pp |
| FY2020 | 21.2% | +6.0 pp |
| FY2019 | 15.2% | +1.1 pp |
| FY2018 | 14.1% | -1.6 pp |
| FY2017 | 15.7% | +1.8 pp |
| FY2016 | 13.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice